164 related articles for article (PubMed ID: 1356426)
1. Platelet monoamine oxidase in schizophrenia: a meta-analysis.
Marcolin MA; Davis JM
Schizophr Res; 1992 Sep; 7(3):249-67. PubMed ID: 1356426
[TBL] [Abstract][Full Text] [Related]
2. Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs.
Kemali D; Maj M; Ariano MG; Salvati A
Encephale; 1985; 11(1):31-4. PubMed ID: 2859981
[TBL] [Abstract][Full Text] [Related]
3. Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients.
Meltzer HY; Duncavage MB; Jackman H; Arora RC; Tricou BJ; Young M
Am J Psychiatry; 1982 Oct; 139(10):1242-8. PubMed ID: 6127035
[TBL] [Abstract][Full Text] [Related]
4. Human platelet MAO in drug-free and medicated schizophrenic patients.
Friedhoff AJ; Miller JC; Weisenfreund J
Am J Psychiatry; 1978 Aug; 135(8):952-5. PubMed ID: 27104
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia and platelet monoamine oxidase: research strategies.
Buchsbaum MS; Coursey RD; Murphy DL
Schizophr Bull; 1980; 6(2):375-84. PubMed ID: 6103578
[TBL] [Abstract][Full Text] [Related]
6. Effects of neuroleptics on platelet monoamine oxidase activity.
Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C
Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230
[TBL] [Abstract][Full Text] [Related]
7. Schizophrenic outcome in late life: symptom state and platelet monoamine oxidase activity.
Bridge TP; Jeste DV; Wise CD; Potkin SG; Phelps BH; Wyatt RJ
Psychiatry Res; 1984 Feb; 11(2):91-7. PubMed ID: 6143337
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia.
Baron M; Gruen R; Levitt M; Kane J
Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754
[TBL] [Abstract][Full Text] [Related]
9. Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment?
Del Vecchio M; Maj M; D'Ambrosio A; Kemali D
Psychopharmacology (Berl); 1983; 79(2-3):177-9. PubMed ID: 6133302
[TBL] [Abstract][Full Text] [Related]
10. Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome.
Mann J; Thomas KM
Br J Psychiatry; 1979 Apr; 134():366-71. PubMed ID: 36192
[TBL] [Abstract][Full Text] [Related]
11. A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.
DeLisi LE; Wise CD; Bridge TP; Rosenblatt JE; Wagner RL; Morihisa J; Karson C; Potkin SG; Wyatt RJ
Psychiatry Res; 1981 Feb; 4(1):95-107. PubMed ID: 6111821
[TBL] [Abstract][Full Text] [Related]
12. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines.
Takahashi S; Yamane H; Tani N
Folia Psychiatr Neurol Jpn; 1975; 29(3):207-14. PubMed ID: 2524
[TBL] [Abstract][Full Text] [Related]
13. Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations.
Rose RM; Castellani S; Boeringa JA; Malek-Ahmadi P; Lankford DA; Bessman JD; Fritz RR; Denney CB; Denney RM; Abell CW
Psychiatry Res; 1986 Feb; 17(2):141-51. PubMed ID: 2870529
[TBL] [Abstract][Full Text] [Related]
14. Platelet monoamine oxidase activity in schizophrenic patients.
Becker RE; Shaskan EG
Am J Psychiatry; 1977 May; 134(5):512-7. PubMed ID: 848577
[TBL] [Abstract][Full Text] [Related]
15. Platelet MAO in schizophrenics: relationship to symptomatology and neuroleptics.
Paik IH; Lee C; Kim CE
Biol Psychiatry; 1988 Jan; 23(1):93-5. PubMed ID: 2892539
[No Abstract] [Full Text] [Related]
16. Poor outcome and low platelet MAO activity in chronic schizophrenia.
Bierer L; Docherty JP; Young JG; Giller E; Cohen D
Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867
[TBL] [Abstract][Full Text] [Related]
17. Blood platelet monoamine oxidase activity in anergic schizophrenics.
Shaskan EG; Becker RE
Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):29-35. PubMed ID: 1233383
[TBL] [Abstract][Full Text] [Related]
18. Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables.
Buckman TD; Kling A; Sutphin MS; Steinberg A; Eiduson S
Psychiatry Res; 1990 Jan; 31(1):1-14. PubMed ID: 1969170
[TBL] [Abstract][Full Text] [Related]
19. MAO inhibitory side effects of neuroleptics and platelet serotonin content in schizophrenic patients.
Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Tekes K; Magyar K
J Neural Transm Suppl; 1998; 52():79-85. PubMed ID: 9564610
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with decreased platelet MAO activity in chronic schizophrenics.
Maj M; Arena F; Galderisi S; Starace F; Kemali D
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(1):79-86. PubMed ID: 2885896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
